Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$444K Sell
23,300
-77,700
-77% -$1.5M ﹤0.01% 2758
2025
Q4
$1.65M Buy
101,000
+8,100
+9% +$143K 0.01% 2020
2025
Q3
$1.75M Buy
92,900
+63,500
+216% +$1.14M 0.01% 1679
2025
Q2
$594K Sell
29,400
-8,100
-22% -$140K ﹤0.01% 2493
2025
Q1
$516K Sell
37,500
-77,800
-67% -$1.07M ﹤0.01% 2537
2024
Q4
$1.37M Buy
115,300
+100,600
+684% +$1.58M ﹤0.01% 2108
2024
Q3
$264K Hold
14,700
﹤0.01% 3807
2024
Q2
$259K Sell
14,700
-136,200
-90% -$2.81M ﹤0.01% 4103
2024
Q1
$3.87M Buy
150,900
+113,900
+308% +$2.86M 0.01% 1493
2023
Q4
$965K Buy
37,000
+600
+2% +$13.7K ﹤0.01% 2375
2023
Q3
$839K Sell
36,400
-32,600
-47% -$817K ﹤0.01% 2401
2023
Q2
$1.62M Buy
69,000
+40,600
+143% +$689K 0.01% 1472
2023
Q1
$337K Buy
+28,400
New +$405K 0.01% 2026

Other funds holding XP

Walleye Capital's XP Position: Q1 2026 in Review

Walleye Capital reduced its XP (XP) stake by 100% in Q1 2026, selling an estimated $317K and leaving 10 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #4290.

Walleye Capital first reported a position in XP in Q4 2020 and has held it in 12 quarters since. The position peaked at $8.4M in Q1 2025. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • Walleye Capital held 10 shares of XP worth $190 as of Q1 2026.
  • Walleye Capital sold 16,422 XP shares in Q1 2026, an estimated $317K.
  • XP made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4290 holding.
  • Walleye Capital first reported a position in XP in Q4 2020 and has held it in 12 quarters since.
  • Walleye Capital's XP position peaked at $8.4M in Q1 2025.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.